Not all doctors are able to treat depression effectively, including those who are most likely to see patients’ first symptoms.
The largest study to date confirms that ketamine — a “club drug” that is also legally used as an anesthetic — could be a quick and effective way to relieve depression.
Here’s a quick look at the biggest health stories this week.
The most popular class of drugs used to treat depression, the selective serotonin reuptake inhibitors (SSRIs), may increase risk of bleeding and the need for blood transfusions following operations, according a study.
Exercise, Prozac and electroconvulsive therapy (ECT) may ultimately relieve depression in the same way.
Painful experiences early in life can alter the brain in lasting ways.
It’s an anesthetic popular with vets, but the latest studies show ketamine also shows promise as a potential antidepressant.
In a new review in Science, the authors call the identification of the anesthetic and “club drug” ketamine as a rapid treatment for depression “arguably the most important discovery in half a century” of research on the condition
In a new book, “Bad Pharma,” British columnist Dr. Ben Goldacre lays out all the clever ways in which the pharmaceutical industry is getting bad drugs onto shelves
Having previous experience with antidepressants can change a person’s future response to both medications and to placebo, according to a new study.
Both antidepressant use and untreated depression in pregnant women may lead to risks for babies. A new study adds data to a troubling problem.
A proposed new definition of depression would include normal bereavement. Why that’s a bad idea.